Givaudan SA
SIX:GIVN

Watchlist Manager
Givaudan SA Logo
Givaudan SA
SIX:GIVN
Watchlist
Price: 3 183 CHF -1.06% Market Closed
Market Cap: 29.4B CHF
Section:
 

Relative Value

The Relative Value of one GIVN stock under the Base Case scenario is 3 873.55 CHF. Compared to the current market price of 3 183 CHF, Givaudan SA is Undervalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GIVN Relative Value
Base Case
3 873.55 CHF
Undervaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.9
P/S
P/S
Price to Sales
3.9
vs History
77
vs Industry
14
Median 3Y
4.4
Median 5Y
4.9
Industry
1.6
Forward
3.8
More Details
26.9
P/E
P/E
Price to Earnings
26.9
vs History
95
vs Industry
22
Median 3Y
33.6
Median 5Y
36.8
Industry
20.8
Forward
24.7
More Details
20.3
P/OCF
P/OCF
Price to OCF
20.3
vs History
95
vs Industry
22
Median 3Y
24.3
Median 5Y
26.6
Industry
13.7
More Details
52.6
P/FCFE
P/FCFE
Price to FCFE
52.6
vs History
7
vs Industry
19
Median 3Y
39
Median 5Y
38.1
Industry
22.1
More Details
7.2
P/B
P/B
Price to Book Value
7.2
vs History
71
vs Industry
5
Median 3Y
7.7
Median 5Y
8.2
Industry
1.7
More Details
4.4
EV/S
EV/S
Enterprise Value to Sales
4.4
vs History
88
vs Industry
12
Median 3Y
4.9
Median 5Y
5.4
Industry
1.8
Forward
4.3
More Details
9.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.9
vs History
95
vs Industry
27
Median 3Y
11.8
Median 5Y
12.5
Industry
7.3
More Details
18.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
18.3
vs History
95
vs Industry
22
Median 3Y
22.4
Median 5Y
23.6
Industry
13.1
Forward
17.6
More Details
23
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23
vs History
95
vs Industry
21
Median 3Y
29.1
Median 5Y
31.1
Industry
17.6
Forward
22
More Details
22.7
EV/OCF
EV/OCF
Enterprise Value to OCF
22.7
vs History
95
vs Industry
22
Median 3Y
27.1
Median 5Y
29.7
Industry
15.2
More Details
29.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
29.6
vs History
92
vs Industry
20
Median 3Y
38.9
Median 5Y
39.4
Industry
21.2
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
66
vs Industry
11
Median 3Y
3.5
Median 5Y
3.8
Industry
1.3
More Details

Multiples Across Competitors

GIVN Competitors Multiples
Givaudan SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Givaudan SA
SIX:GIVN
29.4B CHF 3.9 26.9 18.3 23
US
Sherwin-Williams Co
NYSE:SHW
88.2B USD 3.8 34.3 22.9 26.9
US
Ecolab Inc
NYSE:ECL
78.1B USD 4.9 39.3 22.4 30
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.7T JPY 4.1 21.4 10.4 14.3
CN
Wanhua Chemical Group Co Ltd
SSE:600309
246.4B CNY 1.4 22.2 21.7 21.7
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.6T INR 7.7 67.8 41.9 51.5
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK 9.3 54.8 28.9 37.9
US
PPG Industries Inc
NYSE:PPG
24.5B USD 1.7 24.6 11.2 13.8
CH
Sika AG
F:SIKA
19.9B EUR 1.3 12 8.8 11.1
CH
DSM-Firmenich AG
AEX:DSFIR
18.1B EUR 1.4 72.4 10.7 36.5
US
Albemarle Corp
NYSE:ALB
19.3B USD 3.9 -102.7 30.3 1 011.5
P/E Multiple
Earnings Growth PEG
CH
Givaudan SA
SIX:GIVN
Average P/E: 37.6
26.9
6%
4.5
US
Sherwin-Williams Co
NYSE:SHW
34.3
9%
3.8
US
Ecolab Inc
NYSE:ECL
39.3
9%
4.4
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
21.4
8%
2.7
CN
Wanhua Chemical Group Co Ltd
SSE:600309
22.2
12%
1.9
IN
Asian Paints Ltd
NSE:ASIANPAINT
67.8
15%
4.5
DK
Novozymes A/S
CSE:NZYM B
54.8
N/A N/A
US
PPG Industries Inc
NYSE:PPG
24.6
22%
1.1
CH
Sika AG
F:SIKA
12
6%
2
CH
D
DSM-Firmenich AG
AEX:DSFIR
72.4
68%
1.1
US
Albemarle Corp
NYSE:ALB
Negative Multiple: -102.7 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Givaudan SA
SIX:GIVN
Average EV/EBITDA: 20.7
18.3
5%
3.7
US
Sherwin-Williams Co
NYSE:SHW
22.9
7%
3.3
US
Ecolab Inc
NYSE:ECL
22.4
9%
2.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.4
4%
2.6
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.7
33%
0.7
IN
Asian Paints Ltd
NSE:ASIANPAINT
41.9
11%
3.8
DK
Novozymes A/S
CSE:NZYM B
28.9
N/A N/A
US
PPG Industries Inc
NYSE:PPG
11.2
4%
2.8
CH
Sika AG
F:SIKA
8.8
4%
2.2
CH
D
DSM-Firmenich AG
AEX:DSFIR
10.7
7%
1.5
US
Albemarle Corp
NYSE:ALB
30.3
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Givaudan SA
SIX:GIVN
Average EV/EBIT: 116.2
23
5%
4.6
US
Sherwin-Williams Co
NYSE:SHW
26.9
8%
3.4
US
Ecolab Inc
NYSE:ECL
30
12%
2.5
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
14.3
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.7
8%
2.7
IN
Asian Paints Ltd
NSE:ASIANPAINT
51.5
11%
4.7
DK
Novozymes A/S
CSE:NZYM B
37.9
N/A N/A
US
PPG Industries Inc
NYSE:PPG
13.8
5%
2.8
CH
Sika AG
F:SIKA
11.1
5%
2.2
CH
D
DSM-Firmenich AG
AEX:DSFIR
36.5
36%
1
US
Albemarle Corp
NYSE:ALB
1 011.5
N/A N/A

See Also

Summary
GIVN intrinsic value, competitors valuation, and company profile.
DCF Valuation
GIVN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GIVN stock valuation using valuation multiples.
Wall Street Estimates
GIVN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GIVN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 310,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.